Literature DB >> 7018759

In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions.

M P Cranage, P S Gardner, K McIntosh.   

Abstract

Respiratory syncytial (RS) virus causes a local infection of the respiratory tract which is frequently severe in infants. We report the development in infected infants of antibodies in respiratory secretions capable of mediating in vitro destruction of RS virus-infected tissue culture cells in conjunction with non-immune lymphoid cells. The cytotoxic antibody activity was not detectable in nasal secretions from infants hospitalized with respiratory infections where RS virus was not identified. The rise in activity occurred concurrently with recovery from infection and the rise in specific IgG, IgM and IgA antibody levels measured by membrane immunofluorescence assay, but was dissociated from the development of plaque-neutralizing activity. In serum it appears that the cytotoxic antibody belongs to the IgG class as shown by its ability to cross the placenta and by neutralization with specific antiserum. These findings are discussed in relationship to secretory antibody responses in RS virus infection with respect to pathogenesis and recovery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018759      PMCID: PMC1537123     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.

Authors:  C B Hall; R G Douglas; R L Simons; J M Geiman
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

2.  The coating of respiratory syncytial (RS) virus-infected cells in the respiratory tract by immunoglobulins.

Authors:  P S Gardner; J McQuillin
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

3.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

4.  Kinetics of the respiratory syncytial virus growth cycle in HeLa cells.

Authors:  S Levine; R Hamilton
Journal:  Arch Gesamte Virusforsch       Date:  1969

5.  Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

Authors:  K McIntosh; J McQuillin; P S Gardner
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.

Authors:  R Scott; M O de Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

7.  Breast-feeding protects against respiratory syncytial virus infections.

Authors:  M A Downham; R Scott; D G Sims; J K Webb; P S Gardner
Journal:  Br Med J       Date:  1976-07-31

8.  Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties.

Authors:  H Meguro; M Kervina; P F Wright
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  The immunologic response to infection with respiratory syncytial virus in infants.

Authors:  K McIntosh; H B Masters; I Orr; R K Chao; R M Barkin
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

10.  Pathological changes in virus infections of the lower respiratory tract in children.

Authors:  W Aherne; T Bird; S D Court; P S Gardner; J McQuillin
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

View more
  3 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

3.  Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

Authors:  Alberto Beretta; Martin Cranage; Donato Zipeto
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.